Biotech

All Articles

8 months after a $213M fundraise, gene publisher Volume makes cuts

.After increasing $213 thousand in 2023-- among the year's largest personal biotech rounds-- Tome Bi...

BioMarin builds exec crew along with biotech vets-- Chutes &amp Ladders

.Welcome to today's Chutes &amp Ladders, our summary of significant management hirings, firings as w...

Biopharma Q2 VC reached highest level because '22, while M&ampA reduced

.Financial backing funding right into biopharma cheered $9.2 billion across 215 sell the second four...

Bicara, Zenas find IPOs to push late-phase properties towards market

.Bicara Rehabs and also Zenas Biopharma have actually offered new catalyst to the IPO market along w...

Genentech to shut cancer cells immunology study team

.Genentech will shut its cancer cells immunology investigation department, as well as device mind an...

Kezar goes down sound cyst but to confirm its own truly worth in period 1 test

.Kezar Life Sciences is dropping its own dim period 1 sound growth medication as the biotech goes al...

Acelyrin loses izokibep, lays off 3rd of staff

.Despite izokibep keeping its own newfound winning touch in the medical clinic, Acelyrin is actually...

Rivus' phase 2 obesity-related cardiac arrest test reaches endpoint

.Rivus Pharmaceuticals has plumped up the leads of its fat-busting, muscle-sparing medicine prospect...

Ovid stops preclinical work, IV plan after soticlestat fail

.Ovid Therapeutics currently showed last month that it was trimming its head count as the company br...

Eli Lilly opens up $700M nucleic acid R&ampD facility in Boston ma Port

.Eli Lilly has actually opened a $700 thousand R&ampD center in the Boston ma Seaport, increasing it...